No Prescription, No Dealer, Just a Corner Store: How 7-OH Became America’s Unseen Overdose Crisis
March 26, 2026 — A wave of lawsuits is targeting the makers of concentrated 7-hydroxymitragynine, a synthetic compound derived from the kratom plant but chemically far closer to morphine and fentanyl. The litigation, which spans wrongful death claims and personal injury cases, alleges that manufacturers sold these potent products without proper warnings, fueling a hidden epidemic of addiction, respiratory failure, seizures and fatal overdoses.
7-OH, sometimes labeled as 7-Hydroxy, 7-OHMG or simply “7,” has exploded in availability at gas stations, vape shops and online marketplaces. Often marketed as a “natural” supplement, the compound is a far cry from raw kratom leaves. While natural kratom contains trace amounts of 7-OH — less than 2% of its total alkaloid content — the products now under legal scrutiny are synthetically enhanced to contain the substance at levels up to 500% higher than nature provides, according to the U.S. Food and Drug Administration.
“Vape stores are popping up in every neighborhood in America, and many are selling addictive products like concentrated 7-OH. After the last wave of the opioid epidemic, we cannot get caught flat-footed again,” said FDA Commissioner Marty Makary, M.D., M.P.H. “7-OH is an opioid that can be more potent than morphine. We need regulation and public education to prevent another wave of the opioid epidemic.”
The agency has since recommended that 7-OH be classified as a Schedule I controlled substance, the same category as heroin and LSD, and has seized more than 70,000 units of the compound from three firms in Missouri.
A Deadly Disconnect
The lawsuits argue that a gulf exists between how 7-OH is portrayed and its real-world effects. Several brand names have been named in the litigation, including 7ΩHMZ/7-OHMZ, Hydroxie, Roxytabs, Shaman Botanicals, Thang Botanicals, 7Tabz Retail, RRR Trading (EDP Kratom) and My Smoke Wholesale. Plaintiffs claim they were never adequately warned that the products act on the same mu-opioid receptors in the brain as prescription painkillers and illicit narcotics, carrying a high risk of dependence and life-threatening overdose.
Public health officials are increasingly alarmed. In September 2025, the Los Angeles County Department of Public Health issued an alert after identifying three fatal overdoses in otherwise healthy individuals aged 18 to 40. All had used synthetic 7-OH, often alongside alcohol. A month later, three additional deaths prompted the county to formally warn retailers that 7-OH products “are not lawfully marketed in the U.S.” and to urge residents to carry naloxone, the overdose-reversing drug.
Kansas has reported a dozen or more kratom-related overdose deaths per year in 2022, 2023 and 2024, while a Tampa Bay Times investigation uncovered more than 580 kratom-linked fatalities in Florida over a decade, 46 of which involved kratom alone.
The kratom tree, Mitragyna speciosa, has been used for centuries in Southeast Asia, where leaves are chewed or brewed into tea for mild stimulation and pain relief. The raw plant contains more than 40 alkaloids, but mitragynine and 7-hydroxymitragynine are the two primarily responsible for its psychoactive effects. Because 7-OH exists in such minute quantities in natural leaves, companies have turned to synthetic production to create concentrated tablets, gummies, shots and powders that pack an opioid-like punch.
“Pharmacologically, concentrated 7-OH is more similar to morphine or fentanyl than to raw kratom leaves,” the Blue Ridge Poison Center at UVA Health has noted. The FDA warns that these synthetics are often disguised as candy, ice cream or gummies, putting children and teenagers at risk. An agency campaign dubbed “Hiding in Plain Sight: 7-OH Products” aims to educate families and physicians.
Legal Aftershocks
The legal landscape is already dotted with multimillion-dollar outcomes. In July 2023, a Florida jury awarded $2.5 million to the family of a 39−year−oldman whose death was ruled the “toxic effects of mitragynine”after using Kratom.That same month, a federal judge entered an $11 million judgment against Grow LLC, doing business as The Kratom Distro, for the death of a 39-year-old Florida woman caused by acute mitragynine intoxication.
A class action against Botanic Tonics over its Feel Free Wellness Tonic — a kava-kratom drink that critics said hid kratom’s addictive nature — settled for $8.75 million in 2025. The settlement required the company to add an explicit warning label stating that the product contains “leaf kratom which can become habit-forming and cause serious health effects.”
Now, attorneys are pursuing individual lawsuits on behalf of people who suffered heart attacks, seizures requiring hospitalization, respiratory distress, and addiction severe enough to need medical treatment. Family members of those who died after using 7-OH products are also filing wrongful death claims.
“The harm here is not a small consumer gripe,” one attorney involved in the litigation said, explaining why cases are being handled individually rather than as a class action. “We’re talking about devastating, life-altering injuries and deaths that can warrant substantial damages.”
What Science Says About Risks
The National Institute on Drug Abuse notes that kratom products have been found to contain harmful contaminants such as heavy metals and bacteria. Side effects range from nausea and dizziness to seizures, liver toxicity, and cardiac complications. A 2019 study of poison control calls identified cardiac arrest, dangerous heart rhythms, elevated blood pressure and respiratory depression among reported effects.
Addiction potential is well-documented. The Mayo Clinic reports that some users begin to crave kratom and require treatments like buprenorphine (Suboxone) to quit. The FDA has identified classic signs of substance use disorder in kratom users, including increasing tolerance, loss of control, and painful withdrawal marked by agitation, muscle spasms, vomiting and profound depression.
A Centers for Disease Control and Prevention analysis of overdose deaths between mid-2016 and the end of 2017 found that 152 of 27,338 examined fatalities tested positive for kratom, with the substance listed as a cause of death in 91 cases. While most involved other drugs, seven deaths had kratom as the only substance detected.
What Comes Next
The FDA’s warning letters in July 2025 to companies marketing concentrated 7-OH put the industry on notice that many of these products are considered adulterated or unapproved new drugs. Yet the products continue to appear on shelves, largely because kratom itself is not federally scheduled and oversight falls into a regulatory gray area.
For those who have suffered serious harm, the lawsuits may offer the only route to compensation for medical bills, lost wages, pain and suffering, and funeral costs. But the wider battle over how 7-OH is sold and perceived is only beginning, as families, regulators and the courts grapple with a substance that, as the FDA puts it, has “disturbingly gone mainstream — no prescription needed, no dealer required.”
About the Author
